Streetbeat News

Products Services

HLTH

Cue Health has been granted European Patent Number EP3191849, titled 'Systems and Methods for Detection and Quantification of Analytes'. This patent strengthens Cue Health's intellectual property portfolio in Europe, potentially enhancing its competitive position in the healthcare diagnostics market.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 8:59 pm

PEP

PRMW

A new study suggests boiling drinking water can significantly reduce microplastics, impacting companies like Coca-Cola and PepsiCo, known for their bottled water brands. The presence of microplastics in various environments, including drinking water, has raised health concerns. The study, conducted by researchers from Guangzhou Medical University and Jinan University, found that boiling water can remove up to 90% of microplastics, depending on the water's mineral content. This discovery could influence consumer behavior towards bottled water and tap water treatment methods.

Portfolio Pulse from Natan Ponieman

February 29, 2024 | 8:41 pm

HOOD

Recent options trading activity indicates a bullish stance on Robinhood Markets (NASDAQ:HOOD) by significant investors, with a split sentiment of 50% bullish and 49% bearish. A total of 53 uncommon options trades were spotted, with a price target range of $10.0 to $30.0 over the next three months. The volume and open interest of calls and puts within this range have been analyzed, showing notable trades. Robinhood Markets, known for its financial services platform, has seen its stock price slightly increase to $16.13. Market experts have issued mixed ratings, with a consensus target price of $15.1.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 8:16 pm

AAPL

AMD

HRL

MARA

SNOW

TLT

Wall Street experienced mixed reactions as inflation cooled in January, with the Nasdaq 100 up 0.4%. AMD surged over 6%, hitting a record high, while Apple dropped 1%. Treasury yields fell, boosting the iShares 20+ Year Treasury Bond ETF. Bitcoin declined over 2%. Notable stock movements included Marathon Digital and Snowflake plummeting, while Hormel Foods soared after exceeding earnings expectations.

Portfolio Pulse from Piero Cingari

February 29, 2024 | 7:30 pm

LVTX

LAVA Therapeutics N.V. has filed a U.S. patent application for 'Single Domain Antibodies Targeting CD1D', indicating progress in their research and development efforts. This move could potentially enhance their intellectual property portfolio and strengthen their position in the biotechnology and pharmaceutical industry.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 7:24 pm

Electronic Arts Inc (NASDAQ:EA) has canceled the development of a Star Wars FPS game featuring a Mandalorian protagonist and laid off about 670 employees, 5% of its workforce, as part of a restructuring effort. The company is shifting focus towards its own IPs and key franchises, including the Star Wars: Jedi, Iron Man, Black Panther, and others. Despite these changes, EA reported positive financial results but expects to incur costs related to the layoffs.

Portfolio Pulse from Franca Quarneti

February 29, 2024 | 7:24 pm

AMD

NVDA

SOXL

SOXS

Direxion Daily Semiconductor Bull 3X Shares (SOXL) surged over 7% on Thursday, driven by gains in NVIDIA (NVDA) and AMD, amid a broader semiconductor sector rally. NVIDIA continues to hit new all-time highs after beating quarterly earnings, while AMD benefits from positive sector sentiment. SOXL, which includes AMD and NVIDIA in its holdings, is in an uptrend, but faces bearish divergence on its RSI. The S&P 500's potential breakout and tech stock gains also support the sector's bullish trend. Direxion Daily Semiconductor Bear 3X Shares (SOXS) is an option for bearish traders.

Portfolio Pulse from Melanie Schaffer

February 29, 2024 | 7:16 pm

PFE

Pfizer Inc (NYSE:PFE) announced that its Abrysvo vaccine for respiratory syncytial virus (RSV) in adults 60 and older maintained efficacy through a second RSV season, according to Phase 3 trial data. The vaccine showed 77.8% efficacy against severe RSV after the second season, with overall efficacy across both seasons at 81.5%. No new adverse events were reported in the second season. Abrysvo, approved by the FDA for preventing infection in infants, generated $890 million in sales in fiscal year 2023. PFE shares dropped 1.07% to $26.76.

Portfolio Pulse from Vandana Singh

February 29, 2024 | 7:04 pm

AUMN

BFLY

ENVB

SCTL

Butterfly Network, Inc. (BFLY) shares fell by 22% after reporting a larger-than-expected GAAP loss for Q4, despite beating sales estimates. Other stocks experienced significant movements, with Enveric Biosciences, Inc. (ENVB) and Societal CDMO, Inc. (SCTL) among the top gainers, while J-Long Group Limited (JL) and Golden Minerals Company (AUMN) led the losers.

Portfolio Pulse from Avi Kapoor

February 29, 2024 | 7:00 pm

C3.Ai, Inc. (NYSE:AI) sees positive analyst outlook amid unprecedented AI demand, with Wedbush raising its price target to $40 from $35 following Q3 revenue beat. Other analysts also provided updates, highlighting the company's growth potential, partner ecosystem strength, and the impact of generative AI on customer engagement. Despite concerns about technological differentiation and model visibility, the consensus points towards significant growth opportunities for C3.Ai.

Portfolio Pulse from Nabaparna Bhattacharya

February 29, 2024 | 6:57 pm